glp-1 receptor agonist pancreatitis risk meta-analysis Cardiovascular Effects and Tolerability of Agonists: A Systematic Review and of 99,599 Patients Use of Glucagon-Like Peptide-1 Receptor
Description
Call to action for drug interactions between tirzepatide and heart failure guideline-directed medical therapy
Association of glucagon-like peptide-1 receptor agonists with risk of cancers-evidence from a drug target mendelian randomization and clinical trials
Author Contributions Conceptualization, B.T.B., P.R.R., J.A.A., R.J.J
Proceedings of the National Academy of Sciences of the United States of America, 117 (47), 2995929967
This assumption is supported by a prior outcome trial and observational data 20,41
It is linked to multiple comorbidities like diabetes, arthritis, angina, and hypertension [3, 4]
